Objective: To develop and validate an admission warning strategy that incorporates the general emergency department indicators for predicting the hospital discharge outcome of patients with traumatic brain injury (TBI) in China. Methods: This admission warning strategy was developed in a primary cohort that consisted of 605 patients with TBI who were admitted within 6 h of injury. The least absolute shrinkage and selection operator and multivariable logistic regression analysis were used to develop the early warning strategy of selected indicators. Two sub-cohorts consisting of 180 and 107 patients with TBI were used for the external validation. Results: Indicators of the strategy included three categories: baseline characteristics, imaging and laboratory indicators. This strategy displayed good calibration and good discrimination. A high C-index was reached in the internal validation. The multicenter external validation cohort still showed good discrimination C-indices. Decision curve analysis (DCA) showed the actual needs of this strategy when the possibility threshold was 0.01 for the primary cohort, and at thresholds of 0.02–0.83 and 0.01–0.88 for the two sub-cohorts, respectively. In addition, this strategy exhibited a significant prognostic capacity compared to the traditional single predictors, and this optimization was also observed in two external validation cohorts. Conclusions: We developed and validated an admission warning strategy that can be quickly deployed in the emergency department. This strategy can be used as an ideal tool for predicting hospital discharge outcomes and providing objective evidence for early informed consent of the hospital discharge outcome to the family members of TBI patients.
Cell division control protein 42 homolog (Cdc42), one of the most characteristic members of the Rho protein family, is required for multiple aspects of dendritic morphogenesis. However, the proteins mediating the regulatory effects of Cdc42 activity on neuronal morphology are largely unknown. Cdc42 effector protein‑4 (CEP4) was identified to be a binding partner of Rho GTPase 4 and is ubiquitously expressed in all adult tissues. However, the physiological function of CEP4 in neurons is unknown. In the present study, immunofluorescence and western blot analysis were conducted, revealing that CEP4 is highly expressed in the brain, and that the expression of CEP4 is gradually increased during neurodevelopment. Knockdown of CEP4 with short hairpin RNA suppressed dendrite growth, whereas overexpression of wild‑type CEP4 promoted dendrite growth in primary isolated mouse hippocampal neurons. Collectively, these results indicated an important role for CEP4 in dendrite growth in hippocampal neurons.
Background: Glioblastoma (GBM) is characterized by marked malignant-cell plasticity and a complex tumor ecosystem composed of heterogeneous malignant and microenvironmental cell populations. We integrated single-cell and bulk transcriptomic data to characterize reproducible GBM cell and ecosystem-associated states, evaluate cross-platform concordance, and examine immune-associated transcriptional programs while distinguishing descriptive associations from mechanistic inference. Methods: The deposited Smart-seq2 (7,930 cells) and 10x (16,201 cells) expression matrices from GSE131928/SCP393 were analyzed on their verified expression scales. Official annotations and malignant-state modules were audited, four broad malignant states were recomputed, and a tumor-held-out machine-learning label-transfer framework was applied to the 10x dataset. Public TCGA-GBM RNA-seq data were used to evaluate state- and microenvironment-associated transcriptional programs and to perform nested prediction benchmarking. Selected ecosystem-associated genes were additionally examined by RT-qPCR in glioma cell lines and normal human astrocytes. Results: Among Smart-seq2 cells, 6,576 malignant cells had valid state scores, whereas 287 alias-affected records were excluded from state-score denominators. The machine-learning label-transfer model achieved an out-of-fold accuracy of 0.998, and malignant-state fractions showed moderate-to-strong concordance across six shared tumor labels. At the tumor-label level, MES-like fraction was not significantly associated with macrophage fraction (Spearman rho = 0.171, P = 0.395), indicating that ecosystem-level transcriptional association should not be interpreted as a simple directional immune-to-state mechanism. In TCGA-GBM, MES and myeloid-associated programs correlated with immune and stromal expression signatures, whereas survival and 12-month prediction performance remained modest and specification-sensitive. RT-qPCR further demonstrated increased STAT3, CHI3L1, SPP1, and VEGFA expression in glioma cell lines relative to normal human astrocytes. Conclusion: Integrated single-cell and bulk transcriptomic analysis supports reproducible characterization of malignant-cell heterogeneity and immune-associated ecosystem features in IDH-wildtype GBM. Machine-learning-assisted cross-platform analysis provides a reproducible framework for evaluating tumor ecosystem-associated states, while the observed immune-mesenchymal associations remain descriptive rather than causal. Experimental RT-qPCR provides expression-level support for selected ecosystem-associated genes and highlights testable hypotheses for future functional and spatial studies.